VIR — Vir Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Vir Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	737	708	2,402	1,522	905
Net Total Accounts Receivable
Net Total Receivables	—	773	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	772	1,563	2,519	1,588	1,042
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	79.9	130	188	167	123
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	919	1,954	2,802	1,919	1,399
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	99.1	341	511	175	120
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	202	522	724	329	248
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	717	1,432	2,078	1,590	1,150
Total Liabilities & Shareholders' Equity	919	1,954	2,802	1,919	1,399
Total Common Shares Outstanding